| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/16/2010 | US20100316695 Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics |
| 12/16/2010 | US20100316682 Biodegradable Hyaluronic Acid Derivative, Biodegradable Polymeric Micelle Composition and Pharmaceutical or Bioactive Composition |
| 12/16/2010 | US20100316676 Bisphosphonate Compounds and Methods for Bone Resorption Diseases, Cancer, Bone Pain, Immune Disorders, and Infectious Diseases |
| 12/16/2010 | US20100316668 Immunotherapy for prostate cancer using recombinant bacille calmette-guerin expressing prostate specific antigens |
| 12/16/2010 | US20100316658 Method for producing an antitumoral vaccine based on surface endothelial cell antigens |
| 12/16/2010 | US20100316657 Synthetic Archaeal Glycolipid Adjuvants |
| 12/16/2010 | US20100316656 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 12/16/2010 | US20100316655 Compounds with mdr1-inverse activity |
| 12/16/2010 | US20100316648 Novel plasminogen receptor, polypeptides and antibodies thereof |
| 12/16/2010 | US20100316645 Bispecific Antigen Binding Proteins |
| 12/16/2010 | US20100316642 Complexes of grp94 with human immunoglobulin g |
| 12/16/2010 | US20100316641 Engineered antibody constant domain molecules |
| 12/16/2010 | US20100316640 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| 12/16/2010 | US20100316639 Biomarkers for igf-1r inhibitor therapy |
| 12/16/2010 | US20100316638 Antibody Formulations and Use Thereof |
| 12/16/2010 | US20100316637 Compositions and Methods for Diagnosing and Treating Cancer |
| 12/16/2010 | US20100316635 Kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same |
| 12/16/2010 | US20100316633 Inhibition of angiogenesis |
| 12/16/2010 | US20100316631 Water Soluble Curcumin-Based Compounds |
| 12/16/2010 | US20100316629 Use of gene expression profiling to predict survival in cancer patient |
| 12/16/2010 | US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases |
| 12/16/2010 | US20100316615 Antisense Oligonucleotides Against VR1 |
| 12/16/2010 | US20100316610 Mutant having uracil phosphoribosyl transferase activity |
| 12/16/2010 | US20100316609 Conditionally Replicating Viruses for Cancer Therapy |
| 12/16/2010 | US20100316604 Interferon lambda fusion polypeptides |
| 12/16/2010 | US20100316603 Combination Immunogene Therapy |
| 12/16/2010 | US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 12/16/2010 | US20100316600 Methods of treating cancer using il-21 |
| 12/16/2010 | US20100316599 Methods of treating cancer using il-21 |
| 12/16/2010 | US20100316598 Methods of treating cancer using il-21 |
| 12/16/2010 | US20100316596 Compositions and methods for treatment of diseases and disorders associated with cytokine signaling |
| 12/16/2010 | US20100316595 Methods for treating renal cell carcinoma |
| 12/16/2010 | US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy |
| 12/16/2010 | US20100316573 Organic Compounds |
| 12/16/2010 | US20100316572 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 12/16/2010 | US20100316568 Diagnostic agent and therapeutic agent for pancreatic cancer |
| 12/16/2010 | US20100316567 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells |
| 12/16/2010 | US20100316566 Radiolabeled hedgehog derivatives for imaging and therapy |
| 12/16/2010 | CA2802334A1 Compositions and methods for imaging tissues, organs and tumors |
| 12/16/2010 | CA2765150A1 2, 3-dihydro-1h-indene compounds and their use to treat cancer |
| 12/16/2010 | CA2765114A1 Hedgehog pathway antagonists and therapeutic applications thereof |
| 12/16/2010 | CA2764983A1 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors |
| 12/16/2010 | CA2764885A1 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak |
| 12/16/2010 | CA2764694A1 Pyridinyl derivatives asinhibitors of enzyme nicotinamide phosphoribosyltransferase |
| 12/16/2010 | CA2764653A1 Tetracyclic compounds |
| 12/16/2010 | CA2764562A1 Vaccine therapy for choroidal neovascularization |
| 12/16/2010 | CA2764103A1 Solid dispersions containing an apoptosis-promoting agent |
| 12/16/2010 | CA2764024A1 Compounds useful for treating cancer |
| 12/16/2010 | CA2763862A1 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms |
| 12/15/2010 | EP2261333A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides |
| 12/15/2010 | EP2261258A1 MCSP-aligned scFv antibody fragments and use of same |
| 12/15/2010 | EP2261256A2 Methods of inhibiting metastasis |
| 12/15/2010 | EP2261250A1 Albumin fusion proteins |
| 12/15/2010 | EP2261249A2 KDR peptides and vaccines comprising the same |
| 12/15/2010 | EP2261248A2 KDR peptides and vaccines comprising the same |
| 12/15/2010 | EP2261247A2 KDR peptides and vaccines comprising the same |
| 12/15/2010 | EP2261235A2 Inhibitors of caspases |
| 12/15/2010 | EP2261234A2 Inhibitors of caspases |
| 12/15/2010 | EP2261233A2 Inhibitors of caspases |
| 12/15/2010 | EP2261232A2 Inhibitors of caspases |
| 12/15/2010 | EP2261229A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 12/15/2010 | EP2261226A1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 12/15/2010 | EP2261223A1 Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 12/15/2010 | EP2261221A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations |
| 12/15/2010 | EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor |
| 12/15/2010 | EP2260903A1 C-19 steroids for therapeutic uses |
| 12/15/2010 | EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 12/15/2010 | EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents |
| 12/15/2010 | EP2260866A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 12/15/2010 | EP2260855A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same |
| 12/15/2010 | EP2260852A2 Bisphosphonate conjugates and methods of making and using the same |
| 12/15/2010 | EP2260846A1 Novel methods for the treatment of cancer |
| 12/15/2010 | EP2260842A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass |
| 12/15/2010 | EP2260832A2 Optimal polymer mixtures for gastric retentive tablets |
| 12/15/2010 | EP2260041A2 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 12/15/2010 | EP2260039A1 Chalcone linked pyrrolo[2,1-c[[1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 12/15/2010 | EP2260038A1 Purine derivatives as a3 receptor- selective agonists |
| 12/15/2010 | EP2260033A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 12/15/2010 | EP2260026A1 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 12/15/2010 | EP2260020A1 Hydroxamate-based inhibitors of deacetylases b |
| 12/15/2010 | EP2259844A1 Compositions and methods for mucositis and oncology therapies |
| 12/15/2010 | EP2259800A1 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 12/15/2010 | EP2259797A2 Methods for treating or preventing colorectal cancer |
| 12/15/2010 | EP2259793A2 Use of corticotropin-releasing factor for the treatment of cancer |
| 12/15/2010 | EP2259792A1 Methods for treating and preventing brain tumors based on bone morphogenetic proteins |
| 12/15/2010 | EP2259791A2 Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer |
| 12/15/2010 | EP2259789A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 12/15/2010 | EP2259788A2 Treatment of bladder diseases with a tlr7 activator |
| 12/15/2010 | EP2048145B1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 12/15/2010 | EP2000465B1 Triazolone derivative |
| 12/15/2010 | EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 12/15/2010 | EP1839677B1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof |
| 12/15/2010 | EP1802295B1 Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof |
| 12/15/2010 | EP1768700B1 Conjugates comprising gm-csf and a polymer |
| 12/15/2010 | EP1694709B1 Recombinant anti-cd64-eta' immunotoxins |
| 12/15/2010 | EP1605937B1 Treatment of proliferative diseases with epothilone derivatives and radiation |
| 12/15/2010 | EP1539818B1 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 12/15/2010 | EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 12/15/2010 | EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 12/15/2010 | EP1411954B1 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |